Literature DB >> 14656624

Imatinib-associated pulmonary alveolar proteinosis.

Ulrich Wagner, Petra Staats, Roland Moll, Ulrich Feek, Claus Vogelmeier, David A Groneberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14656624     DOI： 10.1016/s0002-9343(03)00445-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Imatinib-induced pancreatitis.

Authors:  Mahesh R Varma; Shibi Mathew; Devadas Krishnadas; K R Vinayakumar
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

Review 2.  Anticancer therapy and lung injury: molecular mechanisms.

Authors:  Li Li; Henry Mok; Pavan Jhaveri; Mark D Bonnen; Andrew G Sikora; N Tony Eissa; Ritsuko U Komaki; Yohannes T Ghebre
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-23       Impact factor: 4.512

3.  ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.

Authors:  Mariko Yoshimura; Kensuke Kojima; Rika Tomimasu; Noriyasu Fukushima; Shinichiro Hayashi; Eisaburo Sueoka; Shinya Kimura
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

4.  Nilotinib-induced interstitial lung disease.

Authors:  Se-Il Go; Won Sup Lee; Gyeong-Won Lee; Jung Hun Kang; Myung Hee Kang; Jeong-Hee Lee; Hoon-Gu Kim
Journal:  Int J Hematol       Date:  2013-07-23       Impact factor: 2.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.